NFE2L2 and cancer: Intriguingly, both the cardiac glycoside activity of PBI-05204 that we have previously reported7, 8 as well as the triterpenoid-mediated, Nrf2-inducing activity we report here for CNS neuroprotection are also strongly implicated in anti-cancer applications44, 45.